RPV Stock UPDATES S&P 500 Pure Value Guggenheim (RPV) 54.46 09/22/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
S&P 500 Pure Value Guggenheim (RPV) 54.46 $RPV

The Zacks Analyst Blog Highlights: PowerShares Fundamental Pure Large Growth Portfolio, PowerShares Fundamental Pure Lg Val ETF, Guggenheim S&P 500 Pure Growth ETF, Guggenheim S&P 500 Pure Value ETF and iShares Morningstar Large-Cap Growth ETF
PR Newswire - Fri Aug 29, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the PowerShares Fundamental Pure Large Growth Portfolio (AMEX XLG-Free Report), PowerShares Fundamental Pure Lg Val ETF (AMEX XLV-Free Report), Guggenheim S&P 500 Pure Growth ETF (AMEX:RPG-Free Report), Guggenheim S&P 500 Pure Value ETF (AMEX:RPV-Free Report) and iShares Morningstar Large-Cap Growth ETF (AMEX:JKE-Free Report).

3 Growth ETFs to Buy on Large Cap Surge - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Aug 28, 1:00PM CDT
Investors should focus on these top ranked growth ETFs to ride out surging large cap space.

Are Hewlett-Packard and Valero Energy Bargains Right Now?
Selena Maranjian, The Motley Fool - Motley Fool - Wed Jul 23, 9:59AM CDT
Credit : Stuart , Flickr. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some large-cap value stocks to your portfolio but don't have the time or expertise to hand-pick a few,...

Pump Profits with These Alpha-Generating ETFs - ETF News And Commentary
Sweta Killa - ZACKS - Thu Jul 17, 12:00PM CDT
Looking for higher income? Try these alpha generating ETFs.

ETF Analyst of Zacks Investment Research Sweta Killa highlights: These five ETFs have soared over the last half decade, and could be poised for more gains in the months ahead as well
PR Newswire - Fri Mar 14, 8:30AM CDT
Securities in this article include: Guggenheim S&P SmallCap 600 Pure Value ETF (AMEX:RZV-Free Report), Guggenheim S&P 500 Pure Value ETF (AMEX:RPV-Free Report), PowerShares Nasdaq Internet Portfolio (Nasdaq NQI-Free Report), Guggenheim S&P Equal Weight Consumer Discretionary ETF (AMEX:RCD-Free Report) and Guggenheim S&P MidCap 400 Pure Value ETF (AMEX:RFV-Free Report).

5 Best Performing ETFs of the 5 Year Bull Run - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Mar 12, 11:07AM CDT
These top ranked ETFs have surged over the past five years.

Finally, an ETF Offering Great Value
Ankush Shaw, The Motley Fool - Motley Fool - Tue Jan 14, 2:22PM CST
2013 was truly a landmark year for the stock market. A yearly return of about 30% for the S&P 500 marks its biggest yearly percentage gain in a long time. However, the surge in stocks has left many investors scratching their heads as valuations...

Beat the Market with 'Pure' ETF Strategies - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Thu Jul 18, 12:22PM CDT
ETFs with pure growth and value focus have handily beaten SPY in the last 5 years.

Pure Value, Anyone?
Selena Maranjian, The Motley Fool - Motley Fool - Fri Jul 05, 5:03PM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to focus some of your investing on mid-sized value stocks that exhibit low book-value-to-price and sales-to-price ratios, as well as dividend...

Which S&P ETF Style Is Right For You
Carolyn Pairitz - ETFDB - Wed Feb 20, 7:00AM CST
The expansion of the ETF universe continues to foster innovation as the growing product lineup offers investors numerous instruments for addressing their investment goals. In fact, with over 1,400+ ETPs to choose from, investors likely have multiple...




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading